Simultaneous Combined Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Hyperacute Middle Cerebral Artery M1 occlusion

We investigated the efficacy and safety of combined intravenous (IV) recombinant tissue plasminogen activator (rtPA) and simultaneous endovascular therapy (ET) for hyperacute middle cerebral artery (MCA) M1 occlusion. Between October 2005 and April 2007, in the combined group, 22 patients eligible f...

Full description

Saved in:
Bibliographic Details
Main Authors: Toyota, S., Sugiura, S., Iwaisako, K.
Format: Artigo
Language:Inglês
Published: Centauro S.r.l. 2011
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3278035/
https://ncbi.nlm.nih.gov/pubmed/21561568
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items